NYSEARCA:GDNA Goldman Sachs Human Evolution ETF (GDNA) Price, Holdings, & News → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free GDNA Stock Alerts $68.46 +0.19 (+0.28%) (As of 11/6/2020) Add Compare Share Share Today's Range$67.86▼$68.5750-Day Range$68.46▼$68.4652-Week Range$41.71▼$68.79Volume1,300 shsAverage Volume5,884 shsMarket Capitalization$65.04 millionAssets Under Management$64.11 millionDividend Yield0.57%Net Expense Ratio0.50% Stock AnalysisStock Analysis Get Goldman Sachs Human Evolution ETF alerts: Email Address GDNA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GDNA ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive GDNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Goldman Sachs Human Evolution ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerGoldman Sachs Fund NameGoldman Sachs Motif Human Evolution ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:GDNA Inception Date3/1/2019 Fund ManagerRaj Garigipati, Jamie McGregor WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMotif Human Evolution Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings0 Fund Statistics Assets Under Management$64.11 million Average Daily Volume$9,568.90 Discount/Premium0.09% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorGoldman Sachs Asset Management, L.P. CustodianThe Bank of New York Mellon Corporation DistributorALPS Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares950,000BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Ad Porter & CompanyNew York goes dark, then America.Artificial intelligence is about to trigger a shocking new crisis in New York. Experts warn it could be “the next 9/11” and while New York will be ground zero for this looming catastrophe, it will not be the only state impacted. This crisis could affect 233 million Americans starting at any moment from now. Click here for the full story. Goldman Sachs Human Evolution ETF ExpensesTypeGDNATheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.50%0.57%0.54%0.50%0.51%Other Expenses0.00%0.72%0.54%0.64%0.58%Total Expense0.50%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.76%-0.55%-0.68%-0.57%Net Expense0.50%0.59%0.60%0.58%0.58% Goldman Sachs Human Evolution ETF (GDNA) ExposureGDNA Sector ExposureGDNA Industry ExposureFull Holdings Details Similar ETFsGod Bless America ETFNYSEARCA:YALLStrategas Macro Thematic Opportunities ETFNYSEARCA:SAMTMatthews Asia Innovators Active ETFNYSEARCA:MINVVanEck Social Sentiment ETFNYSEARCA:BUZZUS Vegan Climate ETFNYSEARCA:VEGN GDNA ETF - Frequently Asked Questions How have GDNA shares performed in 2024? Goldman Sachs Human Evolution ETF's stock was trading at $68.46 at the beginning of the year. Since then, GDNA shares have increased by 0.0% and is now trading at $68.46. View the best growth stocks for 2024 here. What does GDNA invest in? Goldman Sachs Human Evolution ETF is a equity fund issued by Goldman Sachs. GDNA focuses on theme investments and follows the Motif Human Evolution Index. The fund's investments total to approximately $64.11 million assets under management. What is the management fee for Goldman Sachs Human Evolution ETF? Goldman Sachs Human Evolution ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for GDNA is 0.50%. What other stocks do shareholders of Goldman Sachs Human Evolution ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Goldman Sachs Human Evolution ETF investors own include Abiomed (ABMD), Catalent (CTLT), Hologic (HOLX), Merck & Co., Inc. (MRK), Net Element (NETE), Novavax (NVAX), Quanterix (QTRX), ARCA biopharma (ABIO), AbbVie (ABBV) and AudioEye (AEYE). How do I buy shares of Goldman Sachs Human Evolution ETF? Shares of GDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:GDNA) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceOptions trading has suddenly become more reliable.Eagle PublishingHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Goldman Sachs Human Evolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.